Diagnostic microbiology and infectious disease · 2024
Urine and serum-based ELISA using a recombinant protein and synthetic peptide for the diagnosis of tegumentary leishmaniasis.
СтатьяОценочное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Freitas Camila S, Câmara Raquel S B, Lage Daniela P, Vale Danniele L, Silva Ana L, Pimenta Breno L, Ludolf Fernanda, Galvani Nathália C, de Jesus Marcelo M, Assis Bárbara P N, Chaves Ana T, Tavares Grasiele S V, Tupinambás Unaí, Chávez-Fumagalli Miguel A, Pascoal Vanessa P M, Eller Marcela T C, Rocha Manoel O da Costa, Christodoulides Myron, Machado-de-Ávila Ricardo A, Gonçalves Denise U, Pereira Isabela A G, Coelho Eduardo A F
Аннотация
The diagnosis of tegumentary leishmaniasis (TL) presents problems by the variable sensitivity and specificity of the tests, and the biological samples used are also invasive. Here, ELISA experiments were performed using paired TL patient urine and serum samples in reaction against the recombinant LiHyS protein, a predicted B cell epitope and parasite antigenic extract (SLA). Two hundred and five paired samples were used, which were provided by TL patients, healthy controls and patients with Chagas disease, leprosy, malaria or HIV-infected. An urine-based ELISA showed sensitivity values of 100%, 92.1%, and 82.5%, when rLiHyS, peptide and SLA were used, respectively; and specificity of 100%, 87.6%, and 79.5%, respectively. A serum-based ELISA showed sensitivity values of 100%, 99.3%, and 81.5%, using rLiHyS, peptide and SLA, respectively, and sensitivity of 100%, 96.5%, and 72.2%, respectively. In both cases, rLiHyS presented the better performance to diagnose TL by using patient serum and urine.